What This Document Is
This document is a focused overview of coordinating care for patients infected with multidrug-resistant organisms (MDROs). It provides a foundational understanding of several key pathogens—including MRSA, VRE, *C. difficile*, *Acinetobacter baumannii*, and Carbapenem-Resistant Enterobacteriaceae (CRE)—that pose significant challenges in healthcare settings, particularly for adult and elderly patients. The content centers on understanding the epidemiology, risk factors, pathophysiology, clinical manifestations, and potential complications associated with these infections.
Why This Document Matters
This information is crucial for healthcare professionals, especially those in adult and elderly care, as MDRO infections are increasingly prevalent and often lead to increased morbidity, mortality, and healthcare costs. Understanding these organisms is vital for implementing appropriate infection control measures, recognizing potential outbreaks, and providing effective patient care. It’s particularly relevant for students in a NUR 343 Adult/Elderly II course, preparing them for real-world clinical scenarios. This resource supports informed decision-making regarding patient isolation, antibiotic stewardship, and preventative strategies.
Common Limitations or Challenges
This document serves as a foundational overview and does *not* provide detailed treatment protocols, specific antibiotic dosages, or comprehensive laboratory procedures. It does not cover all possible MDROs, nor does it delve into the complexities of antibiotic resistance mechanisms at a molecular level. Users will still need access to current clinical guidelines, pharmacology resources, and laboratory manuals for complete patient management.
What This Document Provides
This document includes:
* An overview of contact, airborne, vehicle, and vector transmission.
* Detailed information on the epidemiology and risk factors for Methicillin-Resistant *Staphylococcus aureus* (MRSA).
* Information on Vancomycin-Resistant Enterococci (VRE), including risk factors and complications.
* A discussion of *Clostridioides difficile* infection, including its pathophysiology and potential complications.
* An overview of *Acinetobacter baumannii* and Carbapenem-Resistant Enterobacteriaceae (CRE), including risk factors and clinical manifestations.
* Information on the increasing prevalence and mortality rates associated with CRE infections.
This preview does *not* include detailed treatment algorithms, specific infection control protocols, or in-depth discussions of laboratory testing methodologies. It is designed to provide a high-level understanding of the scope and importance of MDRO infections.
